Bridgewater Associates’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64K | Sell |
11,740
-622,739
| -98% | -$3.49M | ﹤0.01% | 991 |
|
|
2025
Q4 | $4.44M | Buy |
634,479
+150,730
| +31% | +$1.18M | 0.02% | 568 |
|
|
2025
Q3 | $3.74M | Buy |
483,749
+473,309
| +4,534% | +$3.69M | 0.01% | 559 |
|
|
2025
Q2 | $90.9K | Sell |
10,440
-2,358
| -18% | -$17.1K | ﹤0.01% | 585 |
|
|
2025
Q1 | $102K | Sell |
12,798
-16,078
| -56% | -$163K | ﹤0.01% | 661 |
|
|
2024
Q4 | $262K | Sell |
28,876
-83,930
| -74% | -$810K | ﹤0.01% | 644 |
|
|
2024
Q3 | $1.04M | Sell |
112,806
-123,580
| -52% | -$1.02M | 0.01% | 597 |
|
|
2024
Q2 | $2.31M | Sell |
236,386
-38,190
| -14% | -$466K | 0.01% | 504 |
|
|
2024
Q1 | $4.15M | Sell |
274,576
-37,273
| -12% | -$676K | 0.02% | 403 |
|
|
2023
Q4 | $6.72M | Sell |
311,849
-35,721
| -10% | -$659K | 0.04% | 322 |
|
|
2023
Q3 | $6.46M | Buy |
347,570
+26,070
| +8% | +$609K | 0.04% | 310 |
|
|
2023
Q2 | $8.14M | Buy |
321,500
+9,657
| +3% | +$243K | 0.05% | 225 |
|
|
2023
Q1 | $8.08M | Sell |
311,843
-12,453
| -4% | -$333K | 0.05% | 232 |
|
|
2022
Q4 | $7.67M | Sell |
324,296
-89,204
| -22% | -$2.41M | 0.04% | 282 |
|
|
2022
Q3 | $10.5M | Sell |
413,500
-9,331
| -2% | -$327K | 0.05% | 247 |
|
|
2022
Q2 | $14M | Buy |
422,831
+24,509
| +6% | +$1.04M | 0.06% | 266 |
|
|
2022
Q1 | $28.7M | Buy |
398,322
+96,930
| +32% | +$6.98M | 0.12% | 134 |
|
|
2021
Q4 | $27.7M | Buy |
301,392
+31,202
| +12% | +$3.73M | 0.16% | 106 |
|
|
2021
Q3 | $34.3M | Sell |
270,190
-8,368
| -3% | -$1.22M | 0.19% | 100 |
|
|
2021
Q2 | $46.3M | Buy |
278,558
+268,383
| +2,638% | +$43.5M | 0.3% | 65 |
|
|
2021
Q1 | $1.85M | Sell |
10,175
-18,142
| -64% | -$4.21M | 0.02% | 282 |
|
|
2020
Q4 | $5.66M | Buy |
+28,317
| New | +$5.76M | 0.05% | 180 |
|
Other funds holding TDOC
VPM
VCM
VC
